cytarabine and Aging
cytarabine has been researched along with Aging in 32 studies
Research
Studies (32)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (37.50) | 18.7374 |
| 1990's | 5 (15.63) | 18.2507 |
| 2000's | 9 (28.13) | 29.6817 |
| 2010's | 6 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Biol, MC; Galvain, D; Greco, S; Hugueny, I; Lenoir, D; Louisot, P | 1 |
| Gangoso, E; Marques-Torrejon, MA; Pollard, SM | 1 |
| Bixby, DL; Crouch, A; Marini, BL; Nachar, VR; Perissinotti, AJ; Scappaticci, GB; Talpaz, M; Uebel, JR; Vulaj, V | 1 |
| Cooper, R; Hardy, R; Kuh, D; Moore, A; Richards, M | 1 |
| Azizi, AA; Chocholous, M; Höferl, M; Jäger, W; Peyrl, A; Sauermann, R; Slavc, I | 1 |
| Boehm, U; Bourque, CW; Dimou, L; Djogo, T; Gillon, CJ; Kim, JH; Kokoeva, MV; Kryzskaya, D; Liu, X; Mingay, A; Robins, SC; Schneider, S; Storch, KF; Stroh, T | 1 |
| Archer, LE; Damon, LE; Hurd, D; Larson, RA; Linker, CA; Owzar, K; Powell, B | 1 |
| Alibhai, SM; Brandwein, JM; Breunis, H; Buckstein, R; Gupta, V; Li, M; Minden, MD; Mohamedali, H; Timilshina, N; Tomlinson, G | 1 |
| Sekeres, MA; Stone, R | 1 |
| Alvarez-Buylla, A; Caporaso, GL; Chao, MV; Lim, DA | 1 |
| Cecconi, F; D'Sa, C; Flavell, RA; Klocke, BJ; Korsmeyer, SJ; Lindsten, T; Roth, KA; Thompson, CB | 1 |
| Barone, TA; Maslov, AY; Plunkett, RJ; Pruitt, SC | 1 |
| Büchner, T; Creutzig, U; Döhner, H; Reinhardt, D; Sauerland, MC; Schlenk, RF; Zimmermann, M | 1 |
| Freireich, EJ | 1 |
| Ferrell, J; Gray, LE; Kavlock, RJ; Ostby, J | 1 |
| Caporale, R; Cervi, L; Ciolli, S; Giuliani, G; Leoni, F; Pascarella, A; Rossi Ferrini, P; Salti, F | 1 |
| Rivera, AJ; Seger, R; Yablonka-Reuveni, Z | 1 |
| Appelbaum, FR; Banker, DE; Cooper, JJ; Garrido, SM; Kopecky, K; Willman, CL | 1 |
| Amenomori, T; Atogami, S; Fukushima, T; Hayashibara, T; Honda, M; Ikeda, S; Jinnai, I; Kuriyama, K; Kusano, M; Matsuo, T; Miyazaki, Y; Momita, S; Nagai, K; Nonaka, H; Soda, H; Taguchi, J; Tomonaga, M; Toriya, K; Yoshida, S; Yoshida, Y | 1 |
| Adriansson, M; Arheden, K; Axelsson, P; Billström, R; Cervin, A; Fioretos, T; Johansson, B; Mitelman, F; Olofsson, T; Strömbeck, B; Tanke, HJ | 1 |
| Kasubuchi, Y; Kusonoki, T; Shimada, M; Wakaizumi, S | 1 |
| Fenech, M; Neville, S | 1 |
| Baltimore, D; Chun, JJ; Jaenisch, R; Oettinger, MA; Schatz, DG | 1 |
| Bearden, JD; Capizzi, RL; Jackson, DV; Lyerly, ES; Morgan, TM; Muss, HB; Powell, BL; Richards, F; Rosenbaum, DL; White, DR | 1 |
| Nakada, H; Nishimura, M; Nonaka, K; Ohmoto, E; Ohnoshi, T; Takahashi, I | 1 |
| Matsui, K | 1 |
| Bordessoule, D; Brière, J; Castaigne, S; Colombat, P; Donadio, D; Drony, S; Guy, H; Sigaux, F; Solal Celigny, P; Tilly, H | 1 |
| Capizzi, RL; Cooper, MR; Jackson, DV; Muss, HB; Powell, BL; Richards, F; Spurr, CL; Stuart, JJ; White, DR; Zekan, PJ | 1 |
| Coccia, PF; Herzig, GP; Herzig, RH; Lazarus, HM; Wolff, SN | 1 |
| Capizzi, RL; Cheng, E; Cheng, YC; Kute, T; Rathmell, JP; White, JC; Yang, JL | 1 |
| Castaigne, S; Daniel, MT; Degos, L; Sigaux, F; Tilly, H | 1 |
| Goldberg, AL; Goldspink, DF | 1 |
Reviews
5 review(s) available for cytarabine and Aging
| Article | Year |
|---|---|
Older adults with acute myeloid leukemia.
Topics: Acute Disease; Age Factors; Aged; Aging; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cytarabine; Drug Tolerance; Growth Substances; Humans; Leukemia, Myeloid; Recurrence; Remission Induction | 2002 |
Methods for evaluating response to treatment in adult acute leukemia.
Topics: Acute Disease; Adult; Aging; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Clinical Trials as Topic; Cytarabine; Doxorubicin; Drug Therapy, Combination; Glycopeptides; Humans; Leukemia; Models, Biological; Peptide Fragments; Prednisone; Pro-Opiomelanocortin; Prognosis; Prospective Studies; Regression Analysis; Vincristine | 1983 |
Attenuated-dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical results.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Survival Rate | 1995 |
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
Topics: Aging; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Asparaginase; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Middle Aged; Time Factors | 1985 |
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation.
Topics: Aging; Animals; Arabinofuranosyluracil; Biological Transport; Bone Marrow; Cell Line; Cell Membrane; Clinical Trials as Topic; Cytarabine; DNA; Dose-Response Relationship, Drug; Drug Resistance; Half-Life; Humans; Interphase; Leukemia; Leukemia L5178; Time Factors | 1985 |
Trials
5 trial(s) available for cytarabine and Aging
| Article | Year |
|---|---|
Pharmacokinetics and toxicity of intrathecal liposomal cytarabine in children and adolescents following age-adapted dosing.
Topics: Adolescent; Aging; Antimetabolites, Antineoplastic; Brain Neoplasms; Child; Child, Preschool; Cytarabine; Female; Humans; Injections, Spinal; Liposomes; Male | 2014 |
Attenuated-dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical results.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Administration Schedule; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Male; Middle Aged; Survival Rate | 1995 |
Low-dose ara-C therapy for acute myelogenous leukemia in elderly patients.
Topics: Aged; Aging; Clinical Trials as Topic; Cytarabine; Drug Administration Schedule; Female; Granulocytes; Hemorrhage; Humans; Infections; Injections, Subcutaneous; Leukemia, Myeloid, Acute; Leukopenia; Male; Middle Aged; Prospective Studies; Remission Induction; Thrombocytopenia | 1989 |
Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
Topics: Aging; Animals; Antineoplastic Combined Chemotherapy Protocols; Arabinofuranosylcytosine Triphosphate; Asparaginase; Child; Clinical Trials as Topic; Cytarabine; Daunorubicin; DNA; Dose-Response Relationship, Drug; Drug Resistance; Humans; Kinetics; Leukemia; Leukemia, Lymphoid; Middle Aged; Time Factors | 1985 |
Dose-related pharmacologic effects of high-dose ara-C and its self-potentiation.
Topics: Aging; Animals; Arabinofuranosyluracil; Biological Transport; Bone Marrow; Cell Line; Cell Membrane; Clinical Trials as Topic; Cytarabine; DNA; Dose-Response Relationship, Drug; Drug Resistance; Half-Life; Humans; Interphase; Leukemia; Leukemia L5178; Time Factors | 1985 |
Other Studies
25 other study(ies) available for cytarabine and Aging
| Article | Year |
|---|---|
Role of insulin and nutritional factors in intestinal glycoprotein fucosylation during postnatal development.
Topics: Aging; alpha-Fetoproteins; Animal Nutritional Physiological Phenomena; Animals; Asialoglycoproteins; Fetuins; Fucosyltransferases; Galactoside 2-alpha-L-fucosyltransferase; Gene Expression Regulation, Developmental; Glycoproteins; Guanosine Diphosphate Fucose; Insulin; Intestinal Mucosa; Male; Microvilli; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley | 1998 |
Modelling glioblastoma tumour-host cell interactions using adult brain organotypic slice co-culture.
Topics: Aging; Animals; Antigens, CD; Biomarkers, Tumor; Brain; Brain Neoplasms; Cell Communication; Cell Proliferation; Coculture Techniques; Culture Media, Serum-Free; Cytarabine; Dacarbazine; Disease Models, Animal; Endothelial Cells; Glioblastoma; Humans; Mice, Inbred C57BL; Neoplastic Stem Cells; Neural Stem Cells; Organ Specificity; Stem Cell Niche; Temozolomide; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2018 |
Outcomes of previously untreated elderly patients with AML: a propensity score-matched comparison of clofarabine vs. FLAG.
Topics: Adenine Nucleotides; Aged; Aged, 80 and over; Aging; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Case-Control Studies; Chemical and Drug Induced Liver Injury; Clofarabine; Cohort Studies; Combined Modality Therapy; Cost Savings; Costs and Cost Analysis; Cytarabine; Granulocyte Colony-Stimulating Factor; Hospital Costs; Humans; Incidence; Induction Chemotherapy; Length of Stay; Leukemia, Myeloid, Acute; Michigan; Middle Aged; Neutropenia; Propensity Score; Retrospective Studies; Survival Analysis; Tertiary Care Centers; Vidarabine | 2018 |
Age at menopause and lifetime cognition: Findings from a British birth cohort study.
Topics: Adult; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cognition; Cohort Studies; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Memory; Menopause; Middle Aged; Neuropsychological Tests; Nimustine; Socioeconomic Factors; United Kingdom; Verbal Learning | 2018 |
Adult NG2-Glia Are Required for Median Eminence-Mediated Leptin Sensing and Body Weight Control.
Topics: Aging; Animals; Anorexia; Arcuate Nucleus of Hypothalamus; Body Weight; Cell Proliferation; Cytarabine; Dendrites; Electrophysiological Phenomena; Female; Gene Deletion; Leptin; Male; Median Eminence; Mice; Microglia; Mitosis; Neuroglia; Obesity; Phenotype; Receptors, Leptin; Signal Transduction; Weight Gain | 2016 |
Auto-SCT for AML in second remission: CALGB study 9620.
Topics: Adult; Aged; Aging; Antigens, CD34; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Humans; Ideal Body Weight; Infusions, Intravenous; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Remission Induction; Transplantation, Autologous; Treatment Outcome; Treatment Refusal; Young Adult | 2009 |
Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia.
Topics: Activities of Daily Living; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2012 |
Telomerase activity in the subventricular zone of adult mice.
Topics: Aging; Animals; Animals, Newborn; Cell Differentiation; Cell Division; Cell Movement; Cells, Cultured; Cytarabine; Mice; Neurons; Olfactory Bulb; Stem Cells; Telencephalon; Telomerase | 2003 |
Caspase regulation of genotoxin-induced neural precursor cell death.
Topics: Aging; Animals; Apoptotic Protease-Activating Factor 1; bcl-2 Homologous Antagonist-Killer Protein; Blotting, Western; Caspases; Catecholamines; Cell Death; Cells, Cultured; Cytarabine; DNA Damage; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Female; Imidazolines; Immunohistochemistry; Immunosuppressive Agents; Membrane Proteins; Mice; Mice, Inbred Strains; Mice, Knockout; Mutagens; Neurons; Pregnancy; Proteins; Reactive Oxygen Species; Telencephalon; Tumor Suppressor Protein p53; X-Rays | 2003 |
Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice.
Topics: Administration, Oral; Aging; Animals; Antigens, Differentiation; Bromodeoxyuridine; Cell Count; Cell Cycle; Cell Division; Cells, Cultured; Cytarabine; Deoxyuridine; Glial Fibrillary Acidic Protein; Idoxuridine; Intermediate Filament Proteins; Lateral Ventricles; Male; Mice; Minichromosome Maintenance Complex Component 2; Nerve Tissue Proteins; Nestin; Neurons; Nuclear Proteins; Stem Cells | 2004 |
Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.
Topics: Adolescent; Adult; Aging; Antineoplastic Combined Chemotherapy Protocols; Blast Crisis; Bone Marrow; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Etoposide; Female; Humans; Idarubicin; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Male; Prognosis; Risk Factors; Survival Analysis; Treatment Outcome | 2008 |
Assessment of the utility of postnatal testing following prenatal exposure to forty chemicals.
Topics: Abnormalities, Drug-Induced; Aging; Animals; Body Weight; Cricetinae; Cytarabine; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Evaluation Studies as Topic; Female; Gestational Age; Herbicides; Male; Mice; Mortality; Motor Activity; Phenyl Ethers; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains; Reproduction; Teratogens | 1983 |
Fibroblast growth factor promotes recruitment of skeletal muscle satellite cells in young and old rats.
Topics: Aging; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; Cell Division; Cytarabine; Fibroblast Growth Factor 2; Hepatocyte Growth Factor; Immunoblotting; Immunohistochemistry; Male; Muscle Development; Muscle, Skeletal; MyoD Protein; Myogenin; Myosins; Proliferating Cell Nuclear Antigen; Protein Isoforms; Rats; Rats, Sprague-Dawley | 1999 |
Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.
Topics: Acute Disease; Adult; Aged; Aging; Antibiotics, Antineoplastic; Antigens, CD34; Antimetabolites, Antineoplastic; Apoptosis; Bone Marrow Cells; Cell Cycle; Cytarabine; Daunorubicin; G2 Phase; Humans; Leukemia, Myeloid; Middle Aged; Mitosis; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-bcl-2; S Phase; Tumor Cells, Cultured | 2001 |
De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapy.
Topics: Acute Disease; Aged; Aged, 80 and over; Aging; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Karyotyping; Leukemia, Myeloid; Male; Mercaptopurine; Middle Aged; Prognosis; Treatment Outcome; Tretinoin | 2001 |
Isodicentric 7p, idic(7)(q11.2), in acute myeloid leukemia associated with older age and favorable response to induction chemotherapy: a new clinical entity?
Topics: Aged; Aged, 80 and over; Aging; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chromosome Banding; Chromosomes, Human, Pair 7; Cytarabine; Female; Humans; Idarubicin; In Situ Hybridization, Fluorescence; Isochromosomes; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Male; Remission Induction; Thioguanine | 2001 |
Cytarabine and its effect on cerebellum of suckling mouse.
Topics: Aging; Animals; Animals, Newborn; Cerebellum; Cytarabine; Mice | 1975 |
Conversion of excision-repairable DNA lesions to micronuclei within one cell cycle in human lymphocytes.
Topics: Adult; Aging; Cell Cycle; Cells, Cultured; Cytarabine; DNA Damage; DNA Repair; Dose-Response Relationship, Drug; Humans; Lymphocytes; Methylnitrosourea; Micronuclei, Chromosome-Defective; Micronucleus Tests; Middle Aged; Regression Analysis | 1992 |
The recombination activating gene-1 (RAG-1) transcript is present in the murine central nervous system.
Topics: Aging; Animals; Base Sequence; Brain; Cell Division; Cell Line; Chromosome Mapping; Cytarabine; Genes; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neurons; Nucleic Acid Hybridization; Oligonucleotide Probes; Organ Specificity; Polymerase Chain Reaction; Recombination, Genetic; RNA Probes; Teratoma; Transcription, Genetic; Tretinoin | 1991 |
[Influences of aging on clinical pictures of hematological diseases: hypoplastic leukemia in the aged].
Topics: Aged; Aging; Antineoplastic Agents; Cytarabine; Humans; Leukemia, Myeloid, Acute | 1987 |
[Changes of ataxia, spontaneous movement and the cerebellar noradrenaline system with aging in ataxic mice].
Topics: Aging; Animals; Ataxia; Cerebellum; Cytarabine; Male; Methoxyhydroxyphenylglycol; Mice; Mice, Inbred C3H; Motor Activity; Norepinephrine; Organ Size | 1986 |
[Treatment of malignant hemopathies with aracytine in low doses. Analysis of 159 cases].
Topics: Aged; Aging; Cytarabine; Humans; Leukemia, Myeloid, Acute; Middle Aged; Myeloproliferative Disorders; Retrospective Studies | 1985 |
Central nervous system toxicity with high-dose cytosine arabinoside.
Topics: Acute Disease; Aging; Central Nervous System Diseases; Combined Modality Therapy; Cytarabine; Drug Evaluation; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma; Middle Aged; Whole-Body Irradiation | 1985 |
Treatment of leukemia with low-dose ara-C: a study of 160 cases.
Topics: Acute Disease; Aged; Aging; Cytarabine; Dose-Response Relationship, Drug; Humans; Leukemia | 1985 |
Problems in the use of (Me- 3H) thymidine for the measurement of DNA synthesis.
Topics: Aging; Animals; Brain; Carbon Isotopes; Cycloheximide; Cytarabine; Dactinomycin; Diaphragm; DNA; Fasting; Kidney; Kinetics; Leucine; Lipids; Liver; Liver Regeneration; Male; Methods; Protein Biosynthesis; Rats; RNA; Thymidine; Tritium | 1973 |